Arterial Stiffness in Patients with Deep and Lobar Intracerebral Hemorrhage
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Intracerebral hemorrhage (ICH) accounts for approximately 10% of stroke cases. Hypertension may play a role in the pathogenesis of ICH that occurs in the basal ganglia, thalamus, pons, and cerebellum, but not in that of lobar ICH. Hypertension contributes to decreased elasticity of arteries, thereby increasing the likelihood of rupture in response to acute elevation in intravascular pressure. This study aimed to evaluate arterial stiffness (using the arterial stiffness index [ASI]) in patients with deep (putaminal and thalamic) ICH in comparison with patients with lobar ICH. Methods We enrolled 64 patients (mean±SD age: 69.3±10.7 years; 47 men and 17 women) among 73 who referred consecutively to our department for intraparenchymal hemorrhage and underwent brain computed tomography (CT) and cerebral angio-CT. In all the subjects, 24-hour heart rates and blood pressures were monitored. The linear regression slope of diastolic on systolic blood pressure was assumed as a global measure of arterial compliance, and its complement (1 minus the slope), ASI, has been considered as a measure of arterial stiffness. Results In the patients with deep ICH, ASI was significantly higher than in the patients with lobar ICH (0.64±0.19 vs. 0.53±0.17, P=0.04). Conclusions Our results suggest that in deep ICH, arterial stiffening represents a possible pathogenetic factor that modifies arterial wall properties and contributes to vascular rupture in response to intravascular pressure acute elevation. Therapeutic strategies that reduce arterial stiffness may potentially lower the incidence of deep hemorrhagic stroke.
Abstract
Background and Purpose Intracerebral hemorrhage (ICH) accounts for approximately 10% of stroke cases. Hypertension may play a role in the pathogenesis of ICH that occurs in the basal ganglia, thalamus, pons, and cerebellum, but not in that of lobar ICH. Hypertension contributes to decreased elasticity of arteries, thereby increasing the likelihood of rupture in response to acute elevation in intravascular pressure. This study aimed to evaluate arterial stiffness (using the arterial stiffness index [ASI]) in patients with deep (putaminal and thalamic) ICH in comparison with patients with lobar ICH. Methods We enrolled 64 patients (mean±SD age: 69.3±10.7 years; 47 men and 17 women) among 73 who referred consecutively to our department for intraparenchymal hemorrhage and underwent brain computed tomography (CT) and cerebral angio-CT. In all the subjects, 24-hour heart rates and blood pressures were monitored. The linear regression slope of diastolic on systolic blood pressure was assumed as a global measure of arterial compliance, and its complement (1 minus the slope), ASI, has been considered as a measure of arterial stiffness. Results In the patients with deep ICH, ASI was significantly higher than in the patients with lobar ICH (0.64±0.19 vs. 0.53±0.17, P=0.04). Conclusions Our results suggest that in deep ICH, arterial stiffening represents a possible pathogenetic factor that modifies arterial wall properties and contributes to vascular rupture in response to intravascular pressure acute elevation. Therapeutic strategies that reduce arterial stiffness may potentially lower the incidence of deep hemorrhagic stroke.
참고문헌 (24)
- van Asch CJ., "Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin : a systematic review and meta-analysis", Lancet Neurol, 9, pp.167~176 (2010)
- Qureshi AI., "Intracerebral haemorrhage", Lancet, 373, pp.1632~1644 (2009)
- Sutherland GR., "Primary intracerebral haemorrhage", J Clin Neurosci, 13, pp.511~517 (2006)
- Labovitz DL., "The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and hispanics", Neurology, 65, pp.518~522 (2005)
- Labovitza DL., "Intracerebral hemorrhage : update", Curr Opin Neurol, 14, pp.103~108 (2001)
- Luft FC., "Molecular mechanisms of arterial stiffness : new insights", J Am Soc Hypertens, 6, pp.436~438 (2012)
- Adji A., "Arterial stiffness, its assessment, prognostic value, and implications for treatment", Am J Hypertens, 24, pp.5~17 (2011)
- Hatanaka R., "Association of arterial stiffness with silent cerebrovascular lesions : the Ohasama study", Cerebrovasc Dis, 31, pp.329~337 (2011)
- Tuttolomondo A., "Arterial stiffness indexes in acute ischemic stroke : relationship with stroke subtype", Atherosclerosis, 211, pp.187~194 (2010)
- Zieman SJ., "Mechanisms, pathophysiology, and therapy of arterial stiffness", Arterioscler Thromb Vasc Biol, 25, pp.932~943 (2005)
- Li Y., "Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring", Hypertension, 47, pp.359~364 (2006)
- Dolan E., "Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study", Hypertension, 47, pp.365~370 (2006)
- Flaherty ML., "Racial variations in location and risk of intracerebral hemorrhage", Stroke, 36, pp.934~937 (2005)
- Keong LH., "The role of a high augmentation index in spontaneous intracerebral hemorrhage to prognosticate mortality", Acta Neurochir Suppl, 111, pp.375~379 (2011)
- Quinn U., "Arterial stiffness", JRSM Cardiovasc Dis, 1 (2012)
- Ochi N., "Silent cerebral microbleeds associated with arterial stiffness in an apparently healthy subject", Hypertens Res, 32, pp.255~260 (2009)
- Song TJ., "The distribution of cerebral microbleeds determines their association with arterial stiffness in non-cardioembolic acute stroke patients", Eur J Neurol, 21, pp.463~469 (2014)
- Laurent S., "Arterial stiffness and stroke in hypertension : therapeutic implications for stroke prevention", CNS Drugs, 19, pp.1~11 (2005)
- Wilkinson I., "Cholesterol, lipids and arterial stiffness", Adv Cardiol, 44, pp.261~277 (2007)
- Mäki-Petäjä KM., "Anti-inflammatory drugs and statins for arterial stiffness reduction", Curr Pharm Des, 15, pp.290~303 (2009)
- Wang ZG., "Relationships between use of statins and arterial stiffness in normotensive and hypertensive patients with coronary artery disease", Chin Med J(Engl), 126, pp.3087~3092 (2013)
- Mäki-Petäjä KM., "Arterial stiffness and inflammation : a potential target for a drug therapy", Artery Res, 4, pp.99~107 (2010)
- Llauradó G., "Advanced glycation end products are associated with arterial stiffness in type 1 diabetes", J Endocrinol, 221, pp.405~413 (2014)
- Stephen EA., "The effect of glycation on arterial microstructure and mechanical response", J Biomed Mater Res A, 102, pp.2565~2572 (2014)
